112
Views
10
CrossRef citations to date
0
Altmetric
Theme: ADHD - Review

Promoting productive interactions between parents and physicians in the treatment of children with attention-deficit/hyperactivity disorder

&
Pages 579-588 | Published online: 09 Jan 2014

References

  • Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch. Pediatr. Adolesc. Med.161(9), 857–864 (2007).
  • Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am. J. Psychiatry157(5), 816–818 (2000).
  • The American Academy of Pediatrics. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics108(4), 1033–1044 (2001).
  • Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry46(7), 894–921 (2007).
  • Care Model for Child Health. In: Improving Care for Children with Attention Deficit Hyperactivity Disorder. National Initiative for Children’s Healthcare Quality, NC, USA, 29–30 (2001).
  • Lopez MA, Toprac MG, Crismon ML, Boemer C, Baumgartner J. A psychoeducational program for children with ADHD or depression and their families: results from the CMAP feasibility study. Community Ment. Health J.41(1), 51–66 (2005).
  • Zito JM, Safer DJ, dosReis S, Magder LS, Gardner JF, Zarin DA. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder. Arch. Pediatr. Adolesc. Med.153(12), 1257–1263 (1999).
  • Zarin DA, Tanielian TL, Suarez AP, Marcus SC. Treatment of attention-deficit hyperactivity disorder by different physician specialties. Psychiatr. Serv.49(2), 171 (1998).
  • Rappley MD, Gardiner JC, Jetton JR, Houang RT. The use of methylphenidate in Michigan. Arch. Pediatr. Adolesc. Med.149(6), 675–679 (1995).
  • Williams J, Klinepeter K, Palmes G, Pulley A, Foy JM. Diagnosis and treatment of behavioral health disorders in pediatric practice. Pediatrics114(3), 601–606 (2004).
  • Toomey SL, Homer CJ, Finkelstein JA. Comparing medical homes for children with ADHD and asthma. Acad. Pediatr.10(1), 56–63 (2010).
  • Toomey SL, Finkelstein J, Kuhlthau K. Does connection to primary care matter for children with attention-deficit/hyperactivity disorder? Pediatrics122(2), 368–374 (2008).
  • Hart CN, Kelleher KJ, Drotar D, Scholle SH. Parent–provider communication and parental satisfaction with care of children with psychosocial problems. Patient Educ. Couns.68(2), 179–185 (2007).
  • Leslie LK, Plemmons D, Monn AR, Palinkas LA. Investigating ADHD treatment trajectories: listening to families’ stories about medication use. J. Dev. Behav. Pediatr.28(3), 179–188 (2007).
  • Leslie LK, Weckerly J, Plemmons D, Landsverk J, Eastman S. Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings. Pediatrics114(1), 129–140 (2004).
  • Brinkman WB, Sherman SN, Zmitrovich AR et al. Parental angst making and revisiting decisions about treatment of ADHD. Pediatrics124, 580–589 (2009).
  • Bussing R, Gary FA. Practice guidelines and parental ADHD treatment evaluations: friends or foes? Harv. Rev. Psychiatry9(5), 223–233 (2001).
  • Charach A, Skyba A, Cook L, Antle BJ. Using stimulant medication for children with ADHD: what do parents say? A brief report. J. Can. Acad. Child Adolesc. Psychiatry15(2), 75–83 (2006).
  • Bussing R, Schoenberg NE, Perwien AR. Knowledge and information about ADHD: evidence of cultural differences among African–American and white parents. Soc. Sci. Med.46(7), 919–928 (1998).
  • Bussing R, Gary FA, Mills TL, Garvan CW. Parental explanatory models of ADHD: gender and cultural variations. Soc. Psychiatry Psychiatr. Epidemiol.38, 563–575 (2003).
  • dosReis S, Mychailyszyn MP, Myers M, Riley AW. Coming to terms with ADHD: how urban African–American families come to seek care for their children. Psychiatr. Serv.58(5), 636–641 (2007).
  • Harborne A, Wolpert M, Clare L. Making sense of ADHD: a battle for understanding? Parents’ views of their children being diagnosed with ADHD. Clin. Child Psychol. Psychiatry9(3), 327–339 (2004).
  • Singh I. Boys will be boys: fathers’ perspectives on ADHD symptoms, diagnosis, and drug treatment. Harv. Rev. Psychiatry11, 308–316 (2003).
  • Singh I. Doing their jobs: mothering with Ritalin in a culture of mother-blame. Soc. Sci. Med.59, 1193–1205 (2004).
  • Leslie LK, Stallone KA, Weckerly J, McDaniel AL, Monn A. Implementing ADHD guidelines in primary care: does one size fit all? J. Health Care Poor Underserved17(2), 302–327 (2006).
  • Kwasman A, Tinsley BJ, Lepper HS. Pediatricians’ knowledge and attitudes concerning diagnosis and treatment of attention deficit and hyperactivity disorders. A national survey approach. Arch. Pediatr. Adolesc. Med.149(11), 1211–1216 (1995).
  • Epstein JN, Langberg JM, Lichtenstein PK, Mainwaring BA, Luzader CP, Stark LJ. Community-wide intervention to improve the attention-deficit/hyperactivity disorder assessment and treatment practices of community physicians. Pediatrics122, 19–27 (2008).
  • Homer CJ, Horvitz L, Heinrich P, Forbes P, Lesneski C, Phillips J. Improving care for children with attention deficit hyperactivity disorder: assessing the impact of self-assessment and targeted training on practice performance. Ambul. Pediatr.4(5), 436–441 (2004).
  • A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch. Gen. Psychiatry56(12), 1073–1086 (1999).
  • Jensen PS, Hinshaw SP, Swanson JM et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J. Dev. Behav. Pediatr.22(1), 60–73 (2001).
  • Rushton JL, Fant KE, Clark SJ. Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder. Pediatrics114(1), e23–e28 (2004).
  • Gardner W, Kelleher KJ, Wasserman R et al. Primary care treatment of pediatric psychosocial problems: a study from pediatric research in office settings and ambulatory sentinel practice network. Pediatrics106(4), E44 (2000).
  • Rucklidge JJ, Johnstone J, Kaplan BJ. Nutrient supplementation approaches in the treatment of ADHD. Expert Rev. Neurother.9(4), 461–476 (2009).
  • Chan E, Rappaport LA, Kemper KJ. Complementary and alternative therapies in childhood attention and hyperactivity problems. J. Dev. Behav. Pediatr.24(1), 4–8 (2003).
  • Johnston C, Seipp C, Hommersen P, Hoza B, Fine S. Treatment choices and experiences in attention deficit and hyperactivity disorder: relations to parents’ beliefs and attributions. Child Care Health Dev.31(6), 669–677 (2005).
  • Concannon PE, Tang YP. Management of attention deficit hyperactivity disorder: a parental perspective. J. Paediatr. Child Health41(12), 625–630 (2005).
  • Honeycutt C, Sleath B, Bush PJ, Campbell W, Tudor G. Physician use of a participatory decision-making style with children with ADHD and their parents. Patient Educ. Couns.57(3), 327–332 (2005).
  • Liu C, Robin AL, Brenner S, Eastman J. Social acceptability of methylphenidate and behavior modification for treating attention deficit hyperactivity disorder. Pediatrics88(3), 560–565 (1991).
  • Krain AL, Kendall PC, Power TJ. The role of treatment acceptability in the initiation of treatment for ADHD. J. Atten. Disord.9(2), 425–434 (2005).
  • Dosreis S, Zito JM, Safer DJ, Soeken KL, Mitchell JW Jr, Ellwood LC. Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder. J. Dev. Behav. Pediatr.24(3), 155–162 (2003).
  • Leslie LK, Weckerly J, Landsverk J, Hough RL, Hurlburt MS, Wood PA. Racial/ethnic differences in the use of psychotropic medication in high-risk children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry42(12), 1433–1442 (2003).
  • Guevara JP, Feudtner C, Romer D et al. Fragmented care for inner-city minority children with attention-deficit/hyperactivity disorder. Pediatrics116(4), e512–e517 (2005).
  • Hansen DL, Hansen EH. Caught in a balancing act: parents’ dilemmas regarding their ADHD child’s treatment with stimulant medication. Qual. Health Res.16(9), 1267–1285 (2006).
  • Davison J, Ford D. Perceptions of attention deficit hyperactivity disorder in one African American community. J. Negro Educ.70(4), 264–274 (2001).
  • Olaniyan O, dosReis S, Garriett V et al. Community perspectives of childhood behavioral problems and ADHD among African American parents. Ambul. Pediatr.7(3), 226–231 (2007).
  • Perrin JM, Friedman RA, Knilans TK. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder. Pediatrics122(2), 451–453 (2008).
  • Conway J, Wong KK, O’Connell C, Warren AE. Cardiovascular risk screening before starting stimulant medications and prescribing practices of canadian physicians: impact of the Health Canada advisory. Pediatrics122(4), e828–e834 (2008).
  • Greenhill LL, Abikoff HB, Arnold LE et al. Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. J. Am. Acad. Child Adolesc. Psychiatry35(10), 1304–1313 (1996).
  • Greenhill LL, Swanson JM, Vitiello B et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J. Am. Acad. Child Adolesc. Psychiatry40(2), 180–187 (2001).
  • Epstein JN, Rabiner D, Johnson DE et al. Improving attention-deficit/hyperactivity disorder treatment outcomes through use of a collaborative consultation treatment service by community-based pediatricians: a cluster randomized trial. Arch. Pediatr. Adolesc. Med.161(9), 835–840 (2007).
  • Nikles CJ, Mitchell GK, Del Mar CB, Clavarino A, McNairn N. An N-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder. Pediatrics117(6), 2040–2046 (2006).
  • Kent MA, Camfield CS, Camfield PR. Double-blind methylphenidate trials: practical, useful, and highly endorsed by families. Arch. Pediatr. Adolesc. Med.153(12), 1292–1296 (1999).
  • Nikles CJ, Clavarino AM, Del Mar CB. Using N-of-1 trials as a clinical tool to improve prescribing. Br. J. Gen. Pract.55(512), 175–180 (2005).
  • Johnston C, Fine S. Methods of evaluating methylphenidate in children with attention deficit hyperactivity disorder: acceptability, satisfaction, and compliance. J. Pediatr. Psychol.18(6), 717–730 (1993).
  • Schachar RJ, Tannock R, Cunningham C, Corkum PV. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J. Am. Acad. Child Adolesc. Psychiatry36(6), 754–763 (1997).
  • Marcus SC, Wan GJ, Kemner JE, Olfson M. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch. Pediatr. Adolesc. Med.159(6), 572–578 (2005).
  • Cox ER, Motheral BR, Henderson RR, Mager D. Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample. Pediatrics111(2), 237–243 (2003).
  • Firestone P. Factors associated with children’s adherence to stimulant medication. Am. J. Orthopsychiatry52(3), 447–457 (1982).
  • Pliszka SR, Lopez M, Crismon ML et al. A feasibility study of the children’s medication algorithm project (CMAP) algorithm for the treatment of ADHD. J. Am. Acad. Child Adolesc. Psychiatry42(3), 279–287 (2003).
  • Vitiello B, Severe JB, Greenhill LL et al. Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. J. Am. Acad. Child Adolesc. Psychiatry40(2), 188–196 (2001).
  • Berger I, Dor T, Nevo Y, Goldzweig G. Attitudes toward attention-deficit hyperactivity disorder (ADHD) treatment: parents’ and children’s perspectives. J. Child Neurol.23(9), 1036–1042 (2008).
  • Olfson M, Gameroff MJ, Marcus SC, Jensen PS. National trends in the treatment of attention deficit hyperactivity disorder. Am. J. Psychiatry160(6), 1071–1077 (2003).
  • Power TJ, Mautone JA, Manz PH, Frye L, Blum NJ. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges. Pediatrics121(1), e65–e72 (2008).
  • Epstein JN, Langberg JM, Lichtenstein PK et al. Attention-deficit/hyperactivity disorder outcomes for children treated in community-based pediatric settings. Arch. Pediatr. Adolesc. Med.164(2), 160–165 (2010).
  • O’Connor AM, Bennett CL, Stacey D et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst. Rev. (3), CD001431 (2009).
  • Arcia E, Fernandez MC, Jaquez M. Latina mothers’ stances on stimulant medication: complexity, conflict, and compromise. J. Dev. Behav. Pediatr.25(5), 311–317 (2004).
  • Hersh W, Helfand M, Wallace J et al. A systematic review of the efficacy of telemedicine for making diagnostic and management decisions. J. Telemed. Telecare8(4), 197–209 (2002).
  • Hersh WR, Helfand M, Wallace J et al. Clinical outcomes resulting from telemedicine interventions: a systematic review. BMC Med. Inform. Decis. Mak.1, 5 (2001).
  • American Academy of Child and Adolescent Psychiatry Committee on Health Care Access and Economics Task Force on Mental Health. Improving mental health services in primary care: reducing administrative and financial barriers to access and collaboration. Pediatrics123(4), 1248–1251 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.